These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 17482935

  • 1. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
    King CR, Freedland SJ, Terris MK, Kane CJ, Amling CL, Aronson WJ, Presti JC.
    Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
    [Abstract] [Full Text] [Related]

  • 2. Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH.
    King CR, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC.
    Urology; 2007 Apr; 69(4):732-7. PubMed ID: 17445660
    [Abstract] [Full Text] [Related]

  • 3. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P, Katcher J, Levin H, Zippe C, Klein E.
    Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
    [Abstract] [Full Text] [Related]

  • 4. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.
    Patel DA, Presti JC, McNeal JE, Gill H, Brooks JD, King CR.
    J Clin Oncol; 2005 Sep 01; 23(25):6157-62. PubMed ID: 16135482
    [Abstract] [Full Text] [Related]

  • 5. Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening population.
    Berger AP, Deibl M, Strasak A, Bektic J, Pelzer A, Steiner H, Spranger R, Fritsche G, Bartsch G, Horninger W.
    Urology; 2006 Nov 01; 68(5):1067-71. PubMed ID: 17095070
    [Abstract] [Full Text] [Related]

  • 6. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group.
    J Urol; 2003 Jun 01; 169(6):2136-41. PubMed ID: 12771735
    [Abstract] [Full Text] [Related]

  • 7. Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy.
    Patel R, Lepor H, Thiel RP, Taneja SS.
    Urology; 2005 May 01; 65(5):942-6. PubMed ID: 15882728
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy.
    Sengupta S, Myers RP, Slezak JM, Bergstralh EJ, Zincke H, Blute ML.
    J Urol; 2005 Dec 01; 174(6):2191-6. PubMed ID: 16280762
    [Abstract] [Full Text] [Related]

  • 11. PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness.
    Loeb S, Sutherland DE, D'Amico AV, Roehl KA, Catalona WJ.
    Urology; 2008 Nov 01; 72(5):1116-20; discussion 1120. PubMed ID: 18571700
    [Abstract] [Full Text] [Related]

  • 12. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, Tobisu K, Kinukawa N, Naito S.
    BJU Int; 2006 Sep 01; 98(3):549-53. PubMed ID: 16925752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
    Motamedinia P, Korets R, Spencer BA, Benson MC, McKiernan JM.
    Urology; 2008 Nov 01; 72(5):1106-10. PubMed ID: 18602142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?
    Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA, Catalona WJ.
    J Urol; 2007 Jan 01; 177(1):102-6; discussion 106. PubMed ID: 17162013
    [Abstract] [Full Text] [Related]

  • 17. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
    Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll PR.
    J Urol; 2001 Jul 01; 166(1):111-5. PubMed ID: 11435834
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
    Freedland SJ, Kane CJ, Presti JC, Terris MK, Amling CL, Dorey F, Aronson WJ.
    J Urol; 2003 Mar 01; 169(3):969-73. PubMed ID: 12576824
    [Abstract] [Full Text] [Related]

  • 20. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
    Bañez LL, Sun L, Trock BJ, Han M, Partin AW, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Moul JW, Freedland SJ.
    J Urol; 2009 Aug 01; 182(2):491-6; discussion 496-8. PubMed ID: 19524974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.